- In January 2024, W.L. Gore & Associates announced that it had received FDA approval for its lower-profile Viabahn VBX balloon-expandable endoprosthesis. This approval marks a significant advancement in the company's product offerings for vascular interventions. The new device is designed to provide enhanced performance in treating peripheral artery diseases with a more streamlined profile for easier deployment
